US Stock MarketDetailed Quotes

VERA Vera Therapeutics

Watchlist

42.830
-1.370-3.10%

Close Oct 1 16:00 ET

42.830
0.0000.00%

Post 16:22 ET

2.35BMarket Cap-19557P/E (TTM)

Vera Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-39.44%-24.78M

-28.67%-33.83M

-36.37%-92.18M

-18.82%-25.14M

-24.72%-22.97M

6.63%-17.77M

-192.75%-26.29M

-185.12%-67.6M

-228.70%-21.16M

-235.89%-18.42M

Net income from continuing operations

-67.19%-33.71M

5.61%-28.38M

-7.79%-95.99M

20.91%-25.66M

18.54%-20.1M

-35.74%-20.16M

-76.00%-30.07M

-173.10%-89.06M

-92.55%-32.44M

-224.25%-24.68M

Depreciation and amortization

189.17%1.5M

-190.32%-1.47M

-382.98%-4.09M

-95.48%-1.17M

-1,827.63%-2.93M

587.74%517K

-5,722.22%-506K

-580.68%-846K

-1,965.63%-597K

-357.63%-152K

Other non cash items

23.99%889K

-10.71%517K

-62.07%2.22M

1.14%532K

-90.62%396K

30.13%717K

2.66%579K

46.54%5.86M

-89.21%526K

3,477.60%4.22M

Change In working capital

5,242.61%6.14M

-931.15%-8.62M

-186.99%-5.87M

-124.33%-2.08M

-963.23%-4.94M

101.60%115K

-82.33%1.04M

92.17%6.75M

98.88%8.54M

-151.90%-465K

-Change in prepaid assets

218.36%2.72M

-110.46%-392K

102.11%173K

267.84%809K

-1,255.19%-2.09M

36.24%-2.3M

195.10%3.75M

-254.81%-8.18M

-168.27%-482K

-124.37%-154K

-Change in payables and accrued expense

20.49%4.03M

-274.70%-7.6M

-117.50%-3.09M

-122.99%-2.24M

-640.30%-2.17M

226.34%3.35M

-119.95%-2.03M

200.65%17.64M

167.36%9.72M

52.27%402K

-Change in other current assets

104.81%13K

325.00%9K

-178.38%-309K

92.31%-1K

48.48%-34K

10.89%-270K

-101.48%-4K

-117.65%-111K

74.51%-13K

---66K

-Change in other current liabilities

6.32%-623K

6.32%-637K

-1.65%-2.65M

6.35%-649K

-0.62%-651K

-4.56%-665K

-8.63%-680K

---2.6M

---693K

---647K

Cash from discontinued investing activities

Operating cash flow

-39.44%-24.78M

-28.67%-33.83M

-36.37%-92.18M

-18.82%-25.14M

-24.72%-22.97M

6.63%-17.77M

-192.75%-26.29M

-185.12%-67.6M

-228.70%-21.16M

-235.89%-18.42M

Investing cash flow

Cash flow from continuing investing activities

73.77%-22.68M

-1,892.43%-219.29M

44.11%-39.43M

38.10%18.56M

765.08%16.23M

-105.37%-86.45M

131.01%12.23M

-1,578.21%-70.55M

368.74%13.44M

-2.44M

Net PPE purchase and sale

----

-1.61%-63K

---63K

--0

----

---62K

--0

---38K

Net investment purchase and sale

73.87%-22.59M

-1,892.43%-219.29M

44.15%-39.37M

38.57%18.62M

775.60%16.23M

-105.40%-86.45M

131.02%12.23M

---70.49M

--13.44M

---2.4M

Cash from discontinued investing activities

Investing cash flow

73.77%-22.68M

-1,892.43%-219.29M

44.11%-39.43M

38.10%18.56M

765.08%16.23M

-105.37%-86.45M

131.01%12.23M

-1,578.21%-70.55M

368.74%13.44M

---2.44M

Financing cash flow

Cash flow from continuing financing activities

696.06%3.44M

156.09%276.54M

31.01%133.54M

19.89%24.83M

-67.29%297K

800.00%432K

34.53%107.98M

89.18%101.93M

320.83%20.71M

908K

Net issuance payments of debt

----

24.85%24.74M

----

302.68%19.82M

----

Net common stock issuance

--0

150.03%287.54M

33.52%115M

--0

33.52%115M

68.30%86.13M

---1K

--1K

Proceeds from stock option exercised by employees

696.06%3.44M

2,779.58%6.91M

-49.30%1.06M

-89.48%87K

-69.54%297K

819.15%432K

2.56%240K

278.73%2.08M

--827K

--975K

Net other financing activities

--0

-146.80%-17.91M

-19.01%-7.26M

--0

-19.03%-7.26M

-120.51%-6.1M

--67K

---68K

Cash from discontinued financing activities

Financing cash flow

696.06%3.44M

156.09%276.54M

31.01%133.54M

19.89%24.83M

-67.29%297K

800.00%432K

34.53%107.98M

89.18%101.93M

320.83%20.71M

--908K

Net cash flow

Beginning cash position

-49.81%69.11M

4.41%45.68M

-45.29%43.75M

-10.81%27.44M

-33.18%33.89M

23.15%137.68M

-45.29%43.75M

48.10%79.97M

-64.42%30.77M

-44.85%50.72M

Current changes in cash

57.59%-44.02M

-75.06%23.42M

105.33%1.93M

40.48%18.24M

67.68%-6.45M

-69.93%-103.79M

195.07%93.93M

-239.45%-36.22M

299.23%12.98M

-263.82%-19.95M

End cash Position

-25.98%25.09M

-49.81%69.11M

4.41%45.68M

-10.81%27.44M

-33.18%33.89M

23.15%137.68M

-45.29%43.75M

-64.42%30.77M

Free cash flow

-39.94%-24.87M

-28.67%-33.83M

-36.34%-92.24M

-19.11%-25.21M

-24.46%-22.97M

6.65%-17.77M

-192.17%-26.29M

-185.38%-67.66M

-228.70%-21.16M

-236.58%-18.46M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-39.44%-24.78M	-28.67%-33.83M	-36.37%-92.18M	-18.82%-25.14M	-24.72%-22.97M	6.63%-17.77M	-192.75%-26.29M	-185.12%-67.6M	-228.70%-21.16M	-235.89%-18.42M
Net income from continuing operations	-67.19%-33.71M	5.61%-28.38M	-7.79%-95.99M	20.91%-25.66M	18.54%-20.1M	-35.74%-20.16M	-76.00%-30.07M	-173.10%-89.06M	-92.55%-32.44M	-224.25%-24.68M
Depreciation and amortization	189.17%1.5M	-190.32%-1.47M	-382.98%-4.09M	-95.48%-1.17M	-1,827.63%-2.93M	587.74%517K	-5,722.22%-506K	-580.68%-846K	-1,965.63%-597K	-357.63%-152K
Other non cash items	23.99%889K	-10.71%517K	-62.07%2.22M	1.14%532K	-90.62%396K	30.13%717K	2.66%579K	46.54%5.86M	-89.21%526K	3,477.60%4.22M
Change In working capital	5,242.61%6.14M	-931.15%-8.62M	-186.99%-5.87M	-124.33%-2.08M	-963.23%-4.94M	101.60%115K	-82.33%1.04M	92.17%6.75M	98.88%8.54M	-151.90%-465K
-Change in prepaid assets	218.36%2.72M	-110.46%-392K	102.11%173K	267.84%809K	-1,255.19%-2.09M	36.24%-2.3M	195.10%3.75M	-254.81%-8.18M	-168.27%-482K	-124.37%-154K
-Change in payables and accrued expense	20.49%4.03M	-274.70%-7.6M	-117.50%-3.09M	-122.99%-2.24M	-640.30%-2.17M	226.34%3.35M	-119.95%-2.03M	200.65%17.64M	167.36%9.72M	52.27%402K
-Change in other current assets	104.81%13K	325.00%9K	-178.38%-309K	92.31%-1K	48.48%-34K	10.89%-270K	-101.48%-4K	-117.65%-111K	74.51%-13K	---66K
-Change in other current liabilities	6.32%-623K	6.32%-637K	-1.65%-2.65M	6.35%-649K	-0.62%-651K	-4.56%-665K	-8.63%-680K	---2.6M	---693K	---647K
Cash from discontinued investing activities
Operating cash flow	-39.44%-24.78M	-28.67%-33.83M	-36.37%-92.18M	-18.82%-25.14M	-24.72%-22.97M	6.63%-17.77M	-192.75%-26.29M	-185.12%-67.6M	-228.70%-21.16M	-235.89%-18.42M
Investing cash flow
Cash flow from continuing investing activities	73.77%-22.68M	-1,892.43%-219.29M	44.11%-39.43M	38.10%18.56M	765.08%16.23M	-105.37%-86.45M	131.01%12.23M	-1,578.21%-70.55M	368.74%13.44M	-2.44M
Net PPE purchase and sale	----	----	-1.61%-63K	---63K	--0	----	----	---62K	--0	---38K
Net investment purchase and sale	73.87%-22.59M	-1,892.43%-219.29M	44.15%-39.37M	38.57%18.62M	775.60%16.23M	-105.40%-86.45M	131.02%12.23M	---70.49M	--13.44M	---2.4M
Cash from discontinued investing activities
Investing cash flow	73.77%-22.68M	-1,892.43%-219.29M	44.11%-39.43M	38.10%18.56M	765.08%16.23M	-105.37%-86.45M	131.01%12.23M	-1,578.21%-70.55M	368.74%13.44M	---2.44M
Financing cash flow
Cash flow from continuing financing activities	696.06%3.44M	156.09%276.54M	31.01%133.54M	19.89%24.83M	-67.29%297K	800.00%432K	34.53%107.98M	89.18%101.93M	320.83%20.71M	908K
Net issuance payments of debt	----	----	24.85%24.74M	----	----	----	----	302.68%19.82M	----	----
Net common stock issuance	--0	150.03%287.54M	33.52%115M	--0	--0	--0	33.52%115M	68.30%86.13M	---1K	--1K
Proceeds from stock option exercised by employees	696.06%3.44M	2,779.58%6.91M	-49.30%1.06M	-89.48%87K	-69.54%297K	819.15%432K	2.56%240K	278.73%2.08M	--827K	--975K
Net other financing activities	--0	-146.80%-17.91M	-19.01%-7.26M	--0	--0	--0	-19.03%-7.26M	-120.51%-6.1M	--67K	---68K
Cash from discontinued financing activities
Financing cash flow	696.06%3.44M	156.09%276.54M	31.01%133.54M	19.89%24.83M	-67.29%297K	800.00%432K	34.53%107.98M	89.18%101.93M	320.83%20.71M	--908K
Net cash flow
Beginning cash position	-49.81%69.11M	4.41%45.68M	-45.29%43.75M	-10.81%27.44M	-33.18%33.89M	23.15%137.68M	-45.29%43.75M	48.10%79.97M	-64.42%30.77M	-44.85%50.72M
Current changes in cash	57.59%-44.02M	-75.06%23.42M	105.33%1.93M	40.48%18.24M	67.68%-6.45M	-69.93%-103.79M	195.07%93.93M	-239.45%-36.22M	299.23%12.98M	-263.82%-19.95M
End cash Position	-25.98%25.09M	-49.81%69.11M	4.41%45.68M	4.41%45.68M	-10.81%27.44M	-33.18%33.89M	23.15%137.68M	-45.29%43.75M	-45.29%43.75M	-64.42%30.77M
Free cash flow	-39.94%-24.87M	-28.67%-33.83M	-36.34%-92.24M	-19.11%-25.21M	-24.46%-22.97M	6.65%-17.77M	-192.17%-26.29M	-185.38%-67.66M	-228.70%-21.16M	-236.58%-18.46M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data